Insider Name | Buy/Sell | Amount | Shares Change | |||
---|---|---|---|---|---|---|
Aug 07, 2024 | Aug 09, 2024 | Invus Public Equities, L.P. 10% | Sell | $0.19 | $61,206 | -4.85% |
Aug 05, 2024 | Aug 07, 2024 | Invus Public Equities, L.P. 10% | Sell | $0.19 | $41,184 | -3.21% |
Aug 01, 2024 | Aug 05, 2024 | Invus Public Equities, L.P. 10% | Sell | $0.2 | $71,097 | -4.85% |
Jul 26, 2024 | Jul 30, 2024 | Invus Public Equities, L.P. 10% | Sell | $0.23 | $315,262 | -16.06% |
Jun 20, 2024 | Jun 24, 2024 | Rock Edwin Chief Medical Officer | Buy | $0.26 | $78,825 | +30.95% |
Jun 18, 2024 | Jun 20, 2024 | Hahn Brian M. SVP Finance CFO | Buy | $0.25 | $4,335 | +19.85% |
Sep 21, 2023 | Sep 25, 2023 | Rock Edwin Chief Medical Officer | Buy | $1.38 | $90,256 | +14.84% |
May 17, 2023 | May 18, 2023 | Hahn Brian M. SVP Finance CFO | Sell | $1.95 | $7,215 | -6.51% |
May 10, 2023 | May 11, 2023 | Junius Daniel M Dir | Buy | $1.56 | $46,800 | +24.34% |
May 08, 2023 | May 09, 2023 | Johnson Bruce S SVP Chief Commercial Officer | Buy | $1.57 | $21,195 | +8.85% |
Feb 21, 2023 | Feb 23, 2023 | Invus Public Equities, L.P. 10% | Buy | $1.78 | $712,255 | +4.50% |
Feb 15, 2023 | Feb 17, 2023 | Invus Public Equities, L.P. 10% | Buy | $2 | $3M | +15.78% |
Feb 09, 2023 | Feb 13, 2023 | Invus Public Equities, L.P. 10% | Buy | $3.24 | $37,123 | +0.17% |
Jan 25, 2023 | Jan 27, 2023 | Sandell Scott D 10% | Sell | $3.14 | $11M | -42.37% |
Jan 05, 2023 | Jan 06, 2023 | Sandell Scott D 10% | Sell | $2.76 | $196,859 | -0.82% |
Dec 30, 2022 | Jan 04, 2023 | Sandell Scott D 10% | Sell | $2.98 | $1M | -4.38% |
Dec 22, 2022 | Dec 27, 2022 | Rock Edwin Chief Medical Officer | Buy | $2.25 | $247,500 | +26.19% |
Nov 17, 2022 | Nov 18, 2022 | Junius Daniel M Dir | Buy | $1.87 | $37,400 | +24.02% |
Nov 14, 2022 | Nov 16, 2022 | Rock Edwin Chief Medical Officer | Buy | $1.55 | $309,000 | +50.00% |
Nov 11, 2022 | Nov 14, 2022 | Pearson Timothy R Dir | Buy | $1.29 | $25,026 | +44.04% |
Nov 11, 2022 | Nov 14, 2022 | Semerjian Harout CEO | Buy | $1.29 | $32,250 | +50.00% |
Nov 11, 2022 | Nov 14, 2022 | Hahn Brian M. SVP Finance CFO | Buy | $1.06 | $21,200 | +26.03% |
Nov 11, 2022 | Nov 14, 2022 | Magnani John L. SVP of Research CSO | Buy | $1.17 | $52,703 | +10.83% |
Nov 11, 2022 | Nov 14, 2022 | Girard Armand SVP Chief Business Officer | Buy | $1.05 | $6,825 | +18.23% |
Mar 09, 2022 | Mar 10, 2022 | Magnani John L. SVP of Research CSO | Sell | $1.09 | $3,517 | -0.98% |
Mar 09, 2022 | Mar 10, 2022 | Girard Armand SVP Chief Business Officer | Sell | $1.09 | $2,550 | -9.36% |
Mar 09, 2022 | Mar 10, 2022 | Hahn Brian M. SVP Finance CFO | Sell | $1.09 | $3,180 | -7.34% |
Nov 16, 2021 | Nov 18, 2021 | Andrews Patricia S Dir | Buy | $2.05 | $82,000 | +46.92% |
Dec 28, 2020 | Dec 30, 2020 | King Rachel K. Pres CEO | Sell | $3.91 | $329,128 | -13.68% |
Nov 04, 2020 | Nov 06, 2020 | Bvf Partners L P/il 10% | Buy | $2.6 | $3M | +66.77% |